Volume 17, Issue 3, Pages (March 2015)

Slides:



Advertisements
Similar presentations
Volume 15, Issue 6, Pages (June 2012)
Advertisements

Sp1 Suppresses miR-3178 to Promote the Metastasis Invasion Cascade via Upregulation of TRIOBP  Hui Wang, Kai Li, Yu Mei, Xuemei Huang, Zhenglin Li, Qingzhu.
Let-7 microRNA–mediated regulation of IL-13 and allergic airway inflammation  Manish Kumar, MSc, Tanveer Ahmad, MSc, Amit Sharma, PhD, Ulaganathan Mabalirajan,
Takashi Tanaka, Michelle A. Soriano, Michael J. Grusby  Immunity 
Volume 25, Issue 6, Pages (December 2006)
Volume 21, Issue 2, Pages (February 2017)
Volume 28, Issue 2, Pages (February 2008)
Volume 9, Issue 6, Pages (June 2011)
Shitao Li, Lingyan Wang, Michael A. Berman, Ye Zhang, Martin E. Dorf 
Volume 9, Issue 1, Pages (January 2011)
Volume 14, Issue 4, Pages (October 2013)
Volume 11, Issue 6, Pages (June 2012)
Volume 30, Issue 3, Pages (March 2009)
Volume 35, Issue 3, Pages (September 2011)
Volume 7, Issue 3, Pages (March 2010)
Volume 13, Issue 6, Pages (June 2013)
Volume 20, Issue 3, Pages (September 2016)
Yongli Bai, Chun Yang, Kathrin Hu, Chris Elly, Yun-Cai Liu 
Tomoyasu Hattori, Lukasz Stawski, Sashidhar S
Volume 11, Issue 5, Pages (May 2012)
MicroRNA-101 Exerts Tumor-Suppressive Functions in Non-small Cell Lung Cancer through Directly Targeting Enhancer of Zeste Homolog 2  Ji-guang Zhang,
MiTF Regulates Cellular Response to Reactive Oxygen Species through Transcriptional Regulation of APE-1/Ref-1  Feng Liu, Yan Fu, Frank L. Meyskens  Journal.
Volume 5, Issue 1, Pages (January 2009)
MUC1 Oncoprotein Stabilizes and Activates Estrogen Receptor α
Volume 4, Issue 3, Pages (September 2008)
Volume 29, Issue 4, Pages (October 2008)
SUMO Promotes HDAC-Mediated Transcriptional Repression
Volume 23, Issue 10, Pages (October 2015)
Glucose-Induced β-Catenin Acetylation Enhances Wnt Signaling in Cancer
Volume 17, Issue 6, Pages (June 2015)
Volume 35, Issue 3, Pages (September 2011)
Volume 17, Issue 4, Pages (April 2015)
MUC1 Oncoprotein Stabilizes and Activates Estrogen Receptor α
Volume 38, Issue 3, Pages (May 2010)
Glycogen Synthase Kinase 3β Regulates IRF3 Transcription Factor-Mediated Antiviral Response via Activation of the Kinase TBK1  Cao-Qi Lei, Bo Zhong, Yu.
Volume 21, Issue 1, Pages (January 2017)
Volume 14, Issue 4, Pages (February 2016)
Volume 12, Issue 2, Pages (August 2012)
Volume 22, Issue 2, Pages (February 2005)
Volume 14, Issue 2, Pages (August 2013)
Volume 30, Issue 3, Pages (March 2009)
Volume 18, Issue 6, Pages (December 2015)
Volume 10, Issue 3, Pages (September 2006)
Volume 17, Issue 6, Pages (June 2015)
Inhibition of PAX3 by TGF-β Modulates Melanocyte Viability
Volume 13, Issue 4, Pages (April 2008)
Volume 35, Issue 1, Pages (July 2009)
Volume 21, Issue 6, Pages (November 2017)
Volume 12, Issue 3, Pages (September 2012)
Volume 25, Issue 5, Pages (March 2007)
Volume 43, Issue 4, Pages (October 2015)
Volume 13, Issue 12, Pages (December 2015)
MELK Promotes Melanoma Growth by Stimulating the NF-κB Pathway
Volume 3, Issue 1, Pages (January 2013)
Negative Regulation of Tumor Suppressor p53 by MicroRNA miR-504
Hua Gao, Yue Sun, Yalan Wu, Bing Luan, Yaya Wang, Bin Qu, Gang Pei 
Volume 33, Issue 5, Pages (November 2010)
Molecular Therapy - Nucleic Acids
USP15 Negatively Regulates Nrf2 through Deubiquitination of Keap1
Volume 17, Issue 4, Pages (October 2002)
Volume 7, Issue 5, Pages (May 2010)
Volume 18, Issue 2, Pages (August 2015)
Michael U. Shiloh, Paolo Manzanillo, Jeffery S. Cox 
Regulation of KSHV Lytic Switch Protein Expression by a Virus-Encoded MicroRNA: An Evolutionary Adaptation that Fine-Tunes Lytic Reactivation  Priya Bellare,
Constitutive NF-κB activation by the t(11;18)(q21;q21) product in MALT lymphoma is linked to deregulated ubiquitin ligase activity  Honglin Zhou, Ming-Qing.
Volume 33, Issue 1, Pages (July 2010)
Volume 14, Issue 1, Pages (July 2013)
Volume 129, Issue 5, Pages (June 2007)
Volume 23, Issue 4, Pages (April 2015)
A Splicing-Independent Function of SF2/ASF in MicroRNA Processing
Presentation transcript:

Volume 17, Issue 3, Pages 345-356 (March 2015) MicroRNA let-7 Modulates the Immune Response to Mycobacterium tuberculosis Infection via Control of A20, an Inhibitor of the NF-κB Pathway  Manish Kumar, Sanjaya Kumar Sahu, Ranjeet Kumar, Arijita Subuddhi, Ranjan Kumar Maji, Kuladip Jana, Pushpa Gupta, Johanna Raffetseder, Maria Lerm, Zhumur Ghosh, Geert van Loo, Rudi Beyaert, Umesh D. Gupta, Manikuntala Kundu, Joyoti Basu  Cell Host & Microbe  Volume 17, Issue 3, Pages 345-356 (March 2015) DOI: 10.1016/j.chom.2015.01.007 Copyright © 2015 Elsevier Inc. Terms and Conditions

Cell Host & Microbe 2015 17, 345-356DOI: (10.1016/j.chom.2015.01.007) Copyright © 2015 Elsevier Inc. Terms and Conditions

Figure 1 Mtb-Induced Downregulation of let-7f Is Associated with Increased Bacterial Survival (A, B, and E) Let-7f expression. Downregulation of let-7f was analyzed by northern blotting in RAW 264.7 (A and E) or BMDM (B). Downregulation of let-7f was compromised when infection was carried out with the ΔESAT-6 mutant (E) of Mtb. Blots are representative of three independent experiments. (C and D) Pri-let-7f was analyzed by semiquantitative RT-PCR in infected BMDMs (C) or RAW264.7 (D). The bars in the right-hand panels represent densitometric analysis of the gels, Results are means ± SD, n = 3. (F–I) Let-7f downregulation favors bacterial survival in macrophages. Forced expression (F and G) or inhibition (H and I) of let-7f reduced (F and G) or enhanced (H and I) bacterial survival 24 and 48 hr postinfection, suggesting that Mtb- induced downregulation of let-7f promotes bacterial survival in macrophages. Results are means ± SD, n = 3. (J–M) Analysis of let-7f in lungs of infected mice. Mice were infected with Mtb. Let-7f downregulation was observed in lungs at 9 (J and K) and 12 (L and M) weeks postinfection. Numbers in (J) and (L) represent individual mice. Densitometric analysis of northern blots are presented in (K) and (M). Expression of let-7f was normalized to that of control RNA (U6). ∗p < 0.05; ∗∗p < 0.01, ∗∗∗p < 0.001. See also Figures S2 and S3. Cell Host & Microbe 2015 17, 345-356DOI: (10.1016/j.chom.2015.01.007) Copyright © 2015 Elsevier Inc. Terms and Conditions

Figure 2 Let-7f Downregulates Its Target TNFAIP3 (A20) (A) Schematic presentation of base pairing between the 3′ UTR of A20 and let-7f. (B) Let-7f targets the A20 3′ UTR. HEK293 cells were transfected with control miRNA or let-7f mimic alongwith either A20 3′ UTR wild-type (WT) (left panel) or mutant (MUT) (right panel) luciferase reporter construct. Luciferase activity was measured 24 hr posttransfection. Unlike the wild-type, the luciferase activity of the mutant A20 3′ UTR was not inhibited by let-7f. (C and D) Let-7f inhibits Mtb-mediated activation of the A20 3′ UTR. RAW 264.7 cells were cotransfected with A20 3′ UTR along with different concentrations of let-7f mimic. Let-7f mimic inhibited Mtb-induced luciferase activity in a dose-dependent manner (C). (D) RAW264.7 cells were transfected with empty vector or A20 3′ UTR (WT or MUT) and left untreated (−) or infected with Mtb (+). Mtb-induced increase in luciferase activity of the 3′ UTR construct was not observed when a mutant construct was transfected. (E) Association of let-7f with A20. RAW 264.7 cells were cotransfected with c-myc-Ago2 in the presence or absence of let-7f for 24 hr followed by lysis of cells and immunoprecipitation with either anti-c-myc-agarose or protein A/G-agarose (ctrl). qRT-PCR confirmed the presence of A20 in the immunoprecipitates of cells transfected with let-7f. Results are means ± SD; n = 3. Cell Host & Microbe 2015 17, 345-356DOI: (10.1016/j.chom.2015.01.007) Copyright © 2015 Elsevier Inc. Terms and Conditions

Figure 3 Mtb Infection Modulates the Expression of A20 and NF-κB Activity in a let-7f-Dependent Manner (A and B) Transcription of A20 is upregulated during Mtb infection. Upregulation of A20 was quantitated by qRT-PCR 24 hr postinfection (A). Transcription of A20 was also upregulated in the spleens (B) of infected mice (n = 4). (C–F) Expression of A20 is regulated by let-7f. Cells were transfected with either control or let-7f mimic and infected with Mtb for different periods of time. Expression of A20 was monitored by immunoblotting with A20 antibody in RAW264.7 (C and D) or BMDMs (E and F); tubulin, loading control transfection with let-7f mimic led to decreased expression of A20. (G and H) Mtb infection was carried out in cells transfected with let-7f inhibitor, and A20 expression was monitored in a time-dependent manner. Let-7f inhibition enhanced A20 expression. (I) Let-7f regulates NF-κB activity. RAW 264.7 cells showed modulation of NF-κB activity after infection with Mtb. Gradual decrease in NF-κB activity was observed after 6 hr of infection when RAW 264.7 cells were transfected with control mimic. This decrease in NF-κB activity was reversed when macrophages were transfected with let-7f mimic prior to Mtb infection. NF-κB activity was normalized with respect to the activity of uninfected cells and expressed as fold change. For (A) and (I), results represent means ± SD; n = 3. See also Figure S3. Cell Host & Microbe 2015 17, 345-356DOI: (10.1016/j.chom.2015.01.007) Copyright © 2015 Elsevier Inc. Terms and Conditions

Figure 4 A20 Dampens Release of Cytokines and Chemokines from Mtb-Infected Macrophages BMDMs from A20+/+ and A20−/− mice were infected with Mtb for 24 and 48 hr. The release of cytokines (TNF, IL-1β, and IL-6) and chemokines (KC, MCP-1, and MIP-2) was enhanced in the absence of A20. Results represent means ± SD (n = 3). UI, uninfected. Cell Host & Microbe 2015 17, 345-356DOI: (10.1016/j.chom.2015.01.007) Copyright © 2015 Elsevier Inc. Terms and Conditions

Figure 5 Role of A20 and iNOS in Mtb Survival in Macrophages (A) Bacterial survival is compromised in BMDMs lacking A20. Results are means ± SD (n = 3). Comparisons have been made between CFUs from wild-type and A20−/− macrophages at each time point. (B) Following Mtb infection, the release of NO from BMDMs, measured by the accumulation of nitrite, was significantly enhanced in the absence of A20. (C–H) Expression of iNOS (C–F) and nitrite production (G and H) is regulated by let-7f. BMDMs (C and D) or RAW 264.7 (E and F) were transfected with either control or let-7f mimic and infected with Mtb for different periods of time. Expression of iNOS was monitored by immunoblotting with iNOS antibody. Nitrite was measured in the supernatants (G and H) at the indicated time points. Blots are representative of two independent experiments. (I–L) iNOS regulates Mtb-dependent nitrite production and bacterial survival. Cells were cotransfected with let-7f mimic along with either control or nos2 siRNA followed by infection with Mtb and assay of nitrite (I and J) or bacterial survival (K and L) at different periods of time. Results (G–L) represent means ± SD; n = 3. UI, uninfected. Cell Host & Microbe 2015 17, 345-356DOI: (10.1016/j.chom.2015.01.007) Copyright © 2015 Elsevier Inc. Terms and Conditions

Figure 6 let-7f Regulates Cytokine and Chemokine Release in Mtb-Infected RAW264.7 Cells were transfected with control or let-7f mimic (A–F) or let-7f inhibitor (G and H) followed by infection with Mtb for different periods of time. Assays were performed with supernatants. Results represent means ± SD; n = 3. BDL, below detection limit; UI, uninfected. See also Figures S6 and S7. Cell Host & Microbe 2015 17, 345-356DOI: (10.1016/j.chom.2015.01.007) Copyright © 2015 Elsevier Inc. Terms and Conditions

Figure 7 let-7f Enhances Cytokine and Chemokine Release, and Nitrite Production in BMDMs Infected with Mtb BMDMs were transfected with control or let-7f mimic (A–F) or let-7f inhibitor (G and H) followed by infection and assays for cytokines or chemokines as described in Figure 6. Results represent means ± SD; n = 3. BDL, below detection limit; UI, uninfected. (I) Model depicting the cascade of events following Mtb infection involving sequential downregulation of let-7f; upregulation of A20; and downregulation of NF-κB, selected cytokines, chemokines, and nitrite production. See also Figure S7. Cell Host & Microbe 2015 17, 345-356DOI: (10.1016/j.chom.2015.01.007) Copyright © 2015 Elsevier Inc. Terms and Conditions